A diabetic woman with worsening heart failure, hunger, and tremor

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 10, 2003, Pages 882-888

  Skugor, Mario ^a   Siraj, Elias S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; C PEPTIDE; CHOLESTEROL; CORTICOTROPIN; DIAZOXIDE; ENALAPRIL; GLIMEPIRIDE; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; ISOPHANE INSULIN; METFORMIN; METOPROLOL; OCTREOTIDE; PIOGLITAZONE; ROSIGLITAZONE; SIMVASTATIN; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; DIET THERAPY; DISEASE SEVERITY; DYSPNEA; EMERGENCY WARD; EXERCISE; FEMALE; FOOD INTAKE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HUNGER; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIA; INHIBITION KINETICS; INSULIN RELEASE; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; TREMOR; WEIGHT GAIN;

EID: 0142217841     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.10.882     Document Type: Article

References (25)

1. Vinik AI, Pavlik-Renar I. Insulin-producing tumors. Adv Endocrinol Metab 1993; 4:1-27.
2. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 1986, 315:1245-1250.
3. Burge MR, Sood V, Sobhy TA, Rassam AG, Schade DS. Sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus: a review. Diabetes Obes Metab 1999; 1:199-206.
4. Robertson WO. Delayed hypoglycemia after ingestion of a single glipizide tablet. Ann Emerg Med 1999; 33:130-131.
5. Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycemia in patients with type 2 diabetes treated with glimepiride versus glibencamide. Diabetes Metab Res Rev 2001; 17:467-473.
6. Burke CW. Adrenocortical insufficiency. Clin Endocrinol Metab 1985; 14:947-976.
7. Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332:1144-1152.
8. Ensberg M, Gossain VV, Rovner DR. Factitious hypoglycemia. Clues to identifying an elusive disorder. Postgrad Med 1986; 79:79-88.
9. Service FJ. Hypoglycemia. Endocrinol Metab Clin North Am 1997; 26:937-955.
10. Service FJ, O'Brien PC, McMahon MM, Kao PC. C-peptide during the prolonged fast in insulinoma. J Clin Endocrinol Metab 1993; 76:655-659.
11. Oelkers W. Current concepts: Adrenal insufficiency. N Engl J Med 1996; 335:1206-1212.
12. Howell MA, Guly HR. A comparison of glucagon and glucose in prehospital hypoglycemia. J Accid Emerg Med 1997; 14:30-32.
13. Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med 2001; 38:68-78.
14. Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdose. J Clin Endocrinol Metab 1993; 76:752-756.
15. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med 2000; 36:133-138.
16. Skrha J, Svacina S, Sramkova J, Pav J. Use of euglycaemic clamping in evaluation of diazoxide treatment of insulinoma. Eur J Clin Pharm 1989; 36:199-201.
17. Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med 1997; 73:640-641.
18. Seltzer HS. Drug-induced hypoglycemia: a review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18:163-183.
19. Marri G, Cozzolino G, Palumbo R. Glucagon in sulfonylurea hypoglycemia? Lancet 1968; 1:303-304.
20. de Herder WW, Lamberts SW. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 2002; 14:53-57.
21. Ovalle F, Bell DSH. Differing effects of thiazolidinediones on LDL and HDL subfraction of Lp(a). Diabetes 2001; 50(suppl 2):A453-A454, A461-A463.
22. Chu NV, Kim DD, Kong APS, et al. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes mellitus [abstract]. Diabetes 2000; 49(suppl 1):A101.
23. Mehnert H. Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance. Exp Clin Endocrinol Diabetes 2001; 109(suppl 2):S259-S264.
24. Blickle JF. Pharmacologic treatment of postprandial hyperglycemia. Diabetes Metab 2000; 26(suppl 2):20-24.
25. Hanif W, Kumar S. Nateglenide: a new rapid-acting insulinotropic agent. Expert Opin Pharmacother 2001; 2:1027-1031.